NASDAQ:ADGM
Adagio Medical Holdings, Inc.
Adagio Medical Holdings, Inc.'s revenue fell 100.0% in fiscal 2025 to $0. Free cash flow was −$19.4M.Summary generated from Adagio Medical Holdings, Inc.'s SEC filings. Latest annual report filed Mar 27, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$0
Revenue growth−100.0%
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equityn/a
Debt / equity1.70
Free cash flow−$19.4M
FCF marginn/a
Share count changen/a
Financials
| Item | 2023 | 2025 |
|---|---|---|
| Revenue | 0 | 0 |
| Operating income | −28 | −22 |
| Net income | −37 | −25 |
| Free cash flow | −26 | −19 |
Recent filings
- 8-KCurrent report
Oct 1, 2026 - 8-KCosts of exit or disposal activities
Sep 23, 2026 - 8-KNotice of delisting or listing-rule failure
Aug 14, 2026 - 8-KRegulation FD disclosure
Aug 13, 2026 - 4Insider transaction report
Aug 12, 2026 - 4Insider transaction report
Aug 12, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 11, 2026 - 8-KResults of operations and financial condition
Aug 11, 2026